Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.
Research Interests

Papers共 18 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Investigation molecular structure of anticancer drug with topological indices
Lei Huang,Akbar Jahanbani,Xuewu Zuo
Computers in Biology and Medicine (2024): 108806-108806
Cited0Views0WOSBibtex
0
0
Discovery of the first ataxia telangiectasia and Rad3-related (ATR) degraders for cancer treatment
Lei Huang,Jialu Shao, Wenwen Lai,Hongfeng Gu, Jieping Yang,Shi Shi, Shepherd Wufoyrwoth,Zhe Song,Yi Zou,Yungen Xu,Qihua Zhu
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024): 116159-116159
Cited0Views0WOSBibtex
0
0
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li,Bingxin Zhai, Mengxuan Hu,Lei Huang,Shihui Huang,Liu Ye, Xiangying Kong, Jie Xu, Jie Bai, Jingjie Yan, Qichen Zhou,
JOURNAL OF MEDICINAL CHEMISTRYno. 6 (2024): 4916-4935
Cited0Views0Bibtex
0
0
Design, synthesis and biological evaluation of novel DCLK1 inhibitor containing purine skeleton for the treatment of pancreatic cancer
Yuepeng Chen,Liuqiong Meng, Wenze Wang,Liu Ye,Lei Huang,Chenghao Wang,Shuping Wang,Mengyao Li, Yingxin Pei, Shijie Zhang,Yi Zou,Yungen Xu
European Journal of Medicinal Chemistry (2023): 115846-115846
Cited1Views0WOSBibtex
1
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn